(19)
(11) EP 0 397 798 A1

(12)

(43) Date of publication:
22.11.1990 Bulletin 1990/47

(21) Application number: 89902872.0

(22) Date of filing: 03.02.1989
(51) International Patent Classification (IPC): 
C12P 21/ 08( . )
A61K 45/ 00( . )
A61P 29/ 00( . )
C07K 14/ 00( . )
C07K 14/ 42( . )
C07K 14/ 715( . )
C07K 19/ 00( . )
A61K 39/ 395( . )
A61K 47/ 48( . )
A61P 37/ 06( . )
C07K 14/ 415( . )
C07K 14/ 705( . )
C07K 16/ 00( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1989/000440
(87) International publication number:
WO 1989/006968 (10.08.1989 Gazette 1989/18)
(84) Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE

(30) Priority: 03.02.1988 US 19880151744

(71) Applicant: Xoma Corporation
Berkeley California 94710 (US)

(72) Inventors:
  • SCANNON, Patrick, J.
    Davis, CA 95616 (US)
  • HARMON, Richard, C.
    Walnut Creek, CA 94595 (US)

(74) Representative: Glawe, Delfs, Moll & Partner 
Patentanwälte Postfach 26 01 62
D-80058 München
D-80058 München (DE)

   


(54) THERAPEUTIC USE OF ANTI-T CELL IMMUNOTOXIN FOR AUTOIMMUNE DISEASES